JOURNAL ARTICLE
Additional file 1 of PAFAH1B3 predicts poor prognosis and promotes progression in lung adenocarcinoma
Tang, SupingNi, JunChen, BohuaSun, FeiHuang, JinboNi, SongshiTang, Zhiyuan
Year: 2022 Journal: OPAL (Open@LaTrobe) (La Trobe University) Publisher: La Trobe University
Abstract
Additional file 1: Figure S1. PAFAH1B3 expression is up-regulated in LUAD tissues. Figure S2. High PAFAH1B3 expression in LUAD is associated with poor survival of LUAD patients. Figure S3. Overexpression of PAFAH1B3 in SPCA1 cells promote cell proliferation in vitro. Table S1. Univariate and multivariate analysis of prognostic parameters in TCGA LUAD patients using Cox regression.
Keywords:
Nucleofection Gestational period TSG101 Diafiltration Proteogenomics Dysgeusia Liquation Durvalumab Fusible alloy
Metrics
0
Cited By
0.00
FWCI (Field Weighted Citation Impact)
31
Refs
0.39
Citation Normalized Percentile
Is in top 1%
Is in top 10%
Topics
Peptidase Inhibition and Analysis
Health Sciences → Medicine → Oncology
Connective tissue disorders research
Life Sciences → Biochemistry, Genetics and Molecular Biology → Genetics
Ferroptosis and cancer prognosis
Health Sciences → Medicine → Pulmonary and Respiratory Medicine
Related Documents
JOURNAL ARTICLE
PAFAH1B3 predicts poor prognosis and promotes progression in lung adenocarcinoma
Suping TangJun NiBohua ChenFei SunJinbo HuangSongshi NiZhiyuan Tang
Journal: BMC Cancer Year: 2022 Vol: 22 (1)Pages: 525-525
JOURNAL ARTICLE
TOP2A Promotes Lung Adenocarcinoma Cells' Malignant Progression and Predicts Poor Prognosis in Lung Adenocarcinoma
Fan KouHoufang SunLei WuBaihui LiBailu ZhangXuezhou WangLili Yang
Journal: Journal of Cancer Year: 2020 Vol: 11 (9)Pages: 2496-2508
JOURNAL ARTICLE
Additional file 1 of CA916798 predicts poor prognosis and promotes Gefitinib resistance for lung adenocarcinoma
He, JianLan, XiLiu, XiayanDeng, CaixiaLuo, HuWang, YanKang, PingSun, ZhijianZhao, LintaoZhou, Xiangdong
Journal: OPAL (Open@LaTrobe) (La Trobe University) Year: 2023